Candriam SCA’s Medidata Solutions, Inc. MDSO Stock Holding History

Candriam SCA’s Portfolio MDSO Stock Details MDSO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-3,000	Closed	-$270K	–	838
2019 Q2	$270K	Buy	+3,000	New	+$263K	﹤0.01%	785

Other funds holding MDSO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

SCS

Syquant Capital SAS Paris, France $447M AUM 13.04% 1-Year Est. Return

Candriam SCA's MDSO Position: Q3 2019 in Review

Candriam SCA sold out of Medidata Solutions, Inc. (MDSO) in Q3 2019, closing a stake of 3,000 shares — an estimated $270K sold.

Candriam SCA first reported a position in MDSO in Q2 2019 and held it in 1 quarter. The position peaked at $270K in Q2 2019. 281 funds tracked by Wall St. Rank hold MDSO as of Q3 2019.

Candriam SCA reported no remaining Medidata Solutions, Inc. position as of Q3 2019 after selling out during the quarter.
Candriam SCA sold 3,000 Medidata Solutions, Inc. shares in Q3 2019, an estimated $270K.
Candriam SCA first reported a position in Medidata Solutions, Inc. in Q2 2019 and held it in 1 quarter.
Candriam SCA's Medidata Solutions, Inc. position peaked at $270K in Q2 2019.
281 funds tracked by Wall St. Rank held Medidata Solutions, Inc. as of Q3 2019.

Based on Candriam SCA's 13F filing for Q3 2019, filed 21 Oct 2019.